Clinical Trial Update: Neuroblastoma Biology Study

View source ↗

Summary

A neuroblastoma biology study led by the New Approaches to Neuroblastoma Therapy Consortium is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: New Approaches to Neuroblastoma Therapy Consortium | Conditions: Neuroblastoma | Status: RECRUITING